Sabin Vaccine Institute Elects New Trustees Bringing Expertise to Support Program Growth

WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees. Joining the Board are Drs. Elizabeth Fox, Saad Omer and Jacqueline Shea, well-respected leaders whose range of skills and experience promise to advance Sabin’s aim to ensure all people, everywhere get the vaccines they need.

GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute

LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) today announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus.

Amy Finan, chief executive officer of the Sabin Vaccine Institute, discussed Sabin’s commitment to vaccine development and the challenges of developing and bringing vaccines to market.

Why is Sabin committed to vaccine development?

For 25 years, Sabin has been a trusted partner, working with countries, the World Health Organization (WHO), Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, and regional stakeholders to improve immunization.

Last night, more than one hundred guests joined together to honor Dr. Paul Offit as the recipient of the 2018 Sabin Gold Medal. Colleagues, family, friends and peers gathered at the National Academy of Sciences building in Washington, D.C., to celebrate Dr. Offit’s contributions to immunization, including his achievements as the co-inventor of an oral rotavirus vaccine and his leadership as a vocal and dedicated advocate for immunization.

New typhoid conjugate vaccines offer important advantages over prior vaccines, including the ability to protect young children, longer lasting protection, and the potential to be a part of routine immunization of infants.

This past weekend, leaders of the world’s major economies gathered in Hamburg, Germany, for this year’s G20 Summit. Among the issues on the agenda: safeguarding against health crises and strengthening health systems.

Pages